92 related articles for article (PubMed ID: 16726523)
1. Effect of epostane, a competitive inhibitor of the 3beta-hydroxysteroid dehydrogenase enzyme, in cyclic sows.
Martin PA; Hammitt DG; Strohbehn RS; Keister DM
Theriogenology; 1988 Oct; 30(4):823-9. PubMed ID: 16726523
[TBL] [Abstract][Full Text] [Related]
2. Induction of parturition in swine and epostane, a competitive inhibitor of 3 beta-hydroxysteroid dehydrogenase.
Martin PA; Hammitt DG; Strohbehn RS; Keister DM
J Anim Sci; 1987 Feb; 64(2):497-506. PubMed ID: 3470276
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 3 beta-hydroxysteroid dehydrogenase in the sow near term: effects on fetal and maternal steroids and on delivery.
Silver M; Fowden AL
Q J Exp Physiol; 1988 Jan; 73(1):67-78. PubMed ID: 3162325
[TBL] [Abstract][Full Text] [Related]
4. Induction of abortion in early first trimester human pregnancy using epostane.
Webster MA; Gillmer MD
Br J Obstet Gynaecol; 1989 Mar; 96(3):340-5. PubMed ID: 2713292
[TBL] [Abstract][Full Text] [Related]
5. Termination of early pregnancy by the 3 beta-hydroxysteroid dehydrogenase inhibitor epostane.
Crooij MJ; de Nooyer CC; Rao BR; Berends GT; Gooren LJ; Janssens J
N Engl J Med; 1988 Sep; 319(13):813-7. PubMed ID: 3166108
[TBL] [Abstract][Full Text] [Related]
6. Effect of an inhibitor of 3 beta-hydroxysteroid dehydrogenase on progesterone concentrations and embryo survival in sheep.
Ashworth CJ; Wilmut I; Springbett AJ; Webb R
J Endocrinol; 1987 Feb; 112(2):205-13. PubMed ID: 3469294
[TBL] [Abstract][Full Text] [Related]
7. Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys.
Haluska GJ; Cook MJ; Novy MJ
Am J Obstet Gynecol; 1997 Mar; 176(3):682-91. PubMed ID: 9077629
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhibiting 3 beta-hydroxysteroid dehydrogenase on plasma progesterone and other steroids in the pregnant mare near term.
Fowden AL; Silver M
J Reprod Fertil Suppl; 1987; 35():539-45. PubMed ID: 3479607
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) activity in first- and second-trimester human pregnancy and the luteal phase using Epostane.
Pattison NS; Webster MA; Phipps SL; Anderson AB; Gillmer MD
Fertil Steril; 1984 Dec; 42(6):875-81. PubMed ID: 6437877
[TBL] [Abstract][Full Text] [Related]
10. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
Birgerson L; Odlind V
Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of preovulatory gonadotrophin surges by epostane: a new inhibitor of 3 beta-hydroxysteroid dehydrogenase.
DePaolo LV
J Endocrinol; 1988 Jul; 118(1):59-68. PubMed ID: 3137304
[TBL] [Abstract][Full Text] [Related]
12. Reproductive responses, progesterone profiles and ovarian characteristics of cycling, fine-wool ewes treated with an inhibitor of progesterone synthesis (epostane).
Hoefler WC; Holcombe DW; Blackwell JA; Hinrichs BD; Hallford DM
J Anim Sci; 1986 Oct; 63(4):1072-7. PubMed ID: 3771390
[TBL] [Abstract][Full Text] [Related]
13. Epostane in nonpregnant females: effects on progesterone, 17 alpha-hydroxyprogesterone, and 17 beta-estradiol of two dose levels given for one month.
Rannevik G; Doeberl A; Valentin L
Fertil Steril; 1988 Dec; 50(6):893-902. PubMed ID: 3203752
[TBL] [Abstract][Full Text] [Related]
14. Effects of epostane on ovarian levels of progesterone, 17 beta-estradiol, prostaglandin E2, and prostaglandin F2 alpha during ovulation in the gonadotropin-primed immature rat.
Espey LL; Adams RF; Tanaka N; Okamura H
Endocrinology; 1990 Jul; 127(1):259-63. PubMed ID: 2361472
[TBL] [Abstract][Full Text] [Related]
15. 3 beta-hydroxysteroid dehydrogenase inhibitor reduces ovarian steroid production but increases ovulation rate in the ewe: interactions with gonadotrophins and inhibin.
Webb R; Baxter G; McBride D; McNeilly AS
J Endocrinol; 1992 Jul; 134(1):115-25. PubMed ID: 1500839
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of progesterone secretion by a 3 beta-hydroxysteroid dehydrogenase inhibitor in pregnant goats.
Taylor MJ
J Endocrinol; 1987 Jun; 113(3):489-93. PubMed ID: 3625098
[TBL] [Abstract][Full Text] [Related]
17. Increased ovulation rate in gilts after oral administration of epostane.
Fu SL; Dial GD; Keister DM; Butler WR
J Reprod Fertil; 1990 Sep; 90(1):297-304. PubMed ID: 2231549
[TBL] [Abstract][Full Text] [Related]
18. Potentiating effect of epostane on pregnancy terminating activity of RU 486 in the rat.
Vanage G; Kadam PA; Bardin CW; Koide SS
Contraception; 1993 May; 47(5):499-506. PubMed ID: 8513677
[TBL] [Abstract][Full Text] [Related]
19. Effects on maternal and fetal steroid concentrations of induction of parturition in the sheep by inhibition of 3 beta-hydroxysteroid dehydrogenase.
Silver M
J Reprod Fertil; 1988 Mar; 82(2):457-65. PubMed ID: 2834551
[TBL] [Abstract][Full Text] [Related]
20. Interruption of first trimester human pregnancy following Epostane therapy. Effect of prostaglandin E2 pessaries.
Webster MA; Phipps SL; Gillmer MD
Br J Obstet Gynaecol; 1985 Sep; 92(9):963-8. PubMed ID: 3862427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
